163 related articles for article (PubMed ID: 24581722)
1. 1082-39, an analogue of sorafenib, inhibited human cancer cell growth more potently than sorafenib.
Chu JH; Zhao CR; Song ZY; Wang RQ; Qin YZ; Li WB; Qu XJ
Biomed Pharmacother; 2014 Apr; 68(3):335-41. PubMed ID: 24581722
[TBL] [Abstract][Full Text] [Related]
2. 1118-20, an indazole diarylurea compound, inhibits hepatocellular carcinoma HepG2 proliferation and tumour angiogenesis involving Wnt/β-catenin pathway and receptor tyrosine kinases.
Lu YY; Wang JJ; Zhang XK; Li WB; Guo XL
J Pharm Pharmacol; 2015 Oct; 67(10):1393-405. PubMed ID: 26076716
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of fisetin combined with sorafenib in human cervical cancer HeLa cells through activation of death receptor-5 mediated caspase-8/caspase-3 and the mitochondria-dependent apoptotic pathway.
Lin MT; Lin CL; Lin TY; Cheng CW; Yang SF; Lin CL; Wu CC; Hsieh YH; Tsai JP
Tumour Biol; 2016 May; 37(5):6987-96. PubMed ID: 26662956
[TBL] [Abstract][Full Text] [Related]
4. SL1122-37, a novel derivative of sorafenib, has greater effects than sorafenib on the inhibition of human hepatocellular carcinoma (HCC) growth and prevention of angiogenesis.
Qin Y; Lu Y; Wang R; Li W; Qu X
Biosci Trends; 2013 Oct; 7(5):237-44. PubMed ID: 24241174
[TBL] [Abstract][Full Text] [Related]
5. Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic cancer cells.
Yun SM; Jung KH; Lee H; Son MK; Seo JH; Yan HH; Park BH; Hong S; Hong SS
Cancer Lett; 2013 May; 331(2):250-61. PubMed ID: 23340175
[TBL] [Abstract][Full Text] [Related]
6. A novel cromakalim analogue induces cell cycle arrest and apoptosis in human cervical carcinoma HeLa cells through the caspase- and mitochondria-dependent pathway.
Zhang X; Zhao J; Kang S; Yi M; You S; Shin DS; Kim DK
Int J Oncol; 2011 Dec; 39(6):1609-17. PubMed ID: 21833470
[TBL] [Abstract][Full Text] [Related]
7. Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.
Pennarun B; Kleibeuker JH; Boersma-van Ek W; Kruyt FA; Hollema H; de Vries EG; de Jong S
J Pathol; 2013 Feb; 229(3):410-21. PubMed ID: 23132258
[TBL] [Abstract][Full Text] [Related]
8. Iodide- and glucose-handling gene expression regulated by sorafenib or cabozantinib in papillary thyroid cancer.
Ruan M; Liu M; Dong Q; Chen L
J Clin Endocrinol Metab; 2015 May; 100(5):1771-9. PubMed ID: 25768669
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological activities of sorafenib derivatives as antitumor agents.
Yao J; He Z; Chen J; Sun W; Fang H; Xu W
Bioorg Med Chem Lett; 2012 Nov; 22(21):6549-53. PubMed ID: 23021967
[TBL] [Abstract][Full Text] [Related]
10. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells.
Kim DH; Jeong YI; Chung CW; Kim CH; Kwak TW; Lee HM; Kang DH
Int J Nanomedicine; 2013; 8():1697-711. PubMed ID: 23658488
[TBL] [Abstract][Full Text] [Related]
12. Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells.
Jane EP; Premkumar DR; Pollack IF
J Pharmacol Exp Ther; 2006 Dec; 319(3):1070-80. PubMed ID: 16959960
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib potentiates ABT-737-induced apoptosis in human oral cancer cells.
Kim LH; Shin JA; Jang B; Yang IH; Won DH; Jeong JH; Chung TH; Cho NP; Cho SD
Arch Oral Biol; 2017 Jan; 73():1-6. PubMed ID: 27632413
[TBL] [Abstract][Full Text] [Related]
14. Cyclophilin D-mediated apoptosis attributes to sorafenib-induced cytotoxicity in clear cell-renal cell carcinoma.
Hu W; Yuan Q; Liu XH; Zhu HC; Lv SQ; Wang XH
Eur J Pharmacol; 2015 Feb; 749():142-50. PubMed ID: 25614335
[TBL] [Abstract][Full Text] [Related]
15. A novel cyano derivative of 11-keto-β-boswellic acid causes apoptotic death by disrupting PI3K/AKT/Hsp-90 cascade, mitochondrial integrity, and other cell survival signaling events in HL-60 cells.
Khan S; Kaur R; Shah BA; Malik F; Kumar A; Bhushan S; Jain SK; Taneja SC; Singh J
Mol Carcinog; 2012 Sep; 51(9):679-95. PubMed ID: 21751262
[TBL] [Abstract][Full Text] [Related]
16. Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts.
Locatelli SL; Giacomini A; Guidetti A; Cleris L; Mortarini R; Anichini A; Gianni AM; Carlo-Stella C
Leukemia; 2013 Aug; 27(8):1677-87. PubMed ID: 23360848
[TBL] [Abstract][Full Text] [Related]
17. [Gambogenic acid induces mitochondria-dependent apoptosis in human gastric carcinoma cell line].
Wang XC; Zhu GQ; Cheng H; Li QL
Zhong Yao Cai; 2014 Jan; 37(1):95-9. PubMed ID: 25090714
[TBL] [Abstract][Full Text] [Related]
18. Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human oral squamous carcinoma cells KB and KB/VCR: In vitro and in vivo studies.
Yue B; Zhao CR; Xu HM; Li YY; Cheng YN; Ke HN; Yuan Y; Wang RQ; Shi YQ; Lou HX; Qu XJ
Biochim Biophys Acta; 2013 Jan; 1830(1):2194-203. PubMed ID: 23085067
[TBL] [Abstract][Full Text] [Related]
19. Sphaeranthus indicus induces apoptosis through mitochondrial-dependent pathway in HL-60 cells and exerts cytotoxic potential on several human cancer cell lines.
Nahata A; Saxena A; Suri N; Saxena AK; Dixit VK
Integr Cancer Ther; 2013 May; 12(3):236-47. PubMed ID: 22914874
[TBL] [Abstract][Full Text] [Related]
20. Two death pathways induced by sorafenib in myeloma cells: Puma-mediated apoptosis and necroptosis.
Ramírez-Labrada A; López-Royuela N; Jarauta V; Galán-Malo P; Azaceta G; Palomera L; Pardo J; Anel A; Marzo I; Naval J
Clin Transl Oncol; 2015 Feb; 17(2):121-32. PubMed ID: 25037851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
